Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01295346 · ClinicalTrials.gov registry record
Biomarkers of Mild and Moderate Traumatic Brain Injury
A clinical trial, sponsored by Banyan Biomarkers.
- Completed
- Registry status
- 290
- Enrollment target
NCT01295346 is a clinical trial that has completed, run by Banyan Biomarkers. The registered enrollment target is 290 participants.
The verdict
NCT01295346 has completed, sponsored by Banyan Biomarkers.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
The purpose of this study is to assess if putative brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injury severity, occurrence of complications, and outcome, in subjects with mild or moderate TBI. The assay will be evaluated in a sample population of subjects over the age of 18 who have been referred to the health care provider for closed head injury evaluation.
Interventions
- OTHER Head CT scan and blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01295346
The ClinicalTrials.gov registry entry for NCT01295346 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Banyan Biomarkers, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Head CT scan and blood draw is the first listed.
NCT01295346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01295346 about?
NCT01295346 is a clinical study titled "Biomarkers of Mild and Moderate Traumatic Brain Injury". The purpose of this study is to assess if putative brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injury s...
What is the current status of trial NCT01295346?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2011-01. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01295346?
The interventions under investigation include: Head CT scan and blood draw (OTHER).
Who is sponsoring clinical trial NCT01295346?
This trial is sponsored by Banyan Biomarkers, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.